Starting in 2023, BioGaia will be selling probiotics under its own management in Canada. Following the acquisition of Nutraceutics in the US at the end of 2021, BioGaia aims to leverage on operational synergies and as a consequence the company has agreed with its current distributor, Ferring, to terminate the agreement. The decision is part of the company's overall strategy of increasing B2C sales.

The regulatory landscape for BioGaia's probiotic products is very favourable in Canada, enabling the company to communicate health benefits/claims.